The global fill finish manufacturing market is projected to grow from USD 18.36 billion in 2025 to USD 28.14 billion by 2030, ...

The Global Prefilled Syringes Market is entering a transformative era driven by biologics expansion, injectable ...

As detailed in the latest report by Towards Packaging, the global Europe glass prefilled syringes and glass vials packaging ...

Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that ...

Integrated isolators, sterilization technologies, and filling solutions deliver proven sterility, reliability, and efficiency ...

After a series of unfortunate regulatory rejections and manufacturing issues surfaced, Regeneron’s shares dipped to $483 this ...

The Buckland Group launched Quvara Medical as the newest CDMO to debut this year after buying a former Becton Dickinson manufacturing site in the U.K. for an undisclosed price. | The Buckland Group ...

Infant Bacterial Therapeutics AB (IBT) whose mission is to develop and commercialize pharmaceuticals for diseases affecting premature babies and BioConnection, a leading pharmaceutical Contract Manufa ...

Lagos State Police Command has uncovered a clandestine fake pharmaceutical operation in the Ojo area of the state. The police ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.